Million-Woman trial could change breast screening age limits
NCT ID NCT01081288
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 2 times
Summary
This nationwide trial is looking at whether inviting women aged 47-49 and 71-73 for breast screening helps reduce deaths from breast cancer. Over 4 million women across England are taking part. The study compares breast cancer deaths and treatments between those invited and those not, to help guide future NHS screening policy.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
What this could lead to
If successful, this could show that offering breast screening to younger and older women saves lives, potentially expanding NHS screening policy.
What could go wrong
This is an observational trial, not a treatment study. Results may not show a clear benefit, and screening can lead to false alarms or overdiagnosis.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER MORTALITY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Cancer Epidemiology Unit, Richard Doll Building, University of Oxford, Roosevelt Drive
Oxford, OX3 7LF, United Kingdom